EyePoint Pharmaceuticals, Inc. Quarterly Operating Lease, Right-of-Use Asset in USD from Q4 2018 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
EyePoint Pharmaceuticals, Inc. quarterly Operating Lease, Right-of-Use Asset history and growth rate from Q4 2018 to Q2 2024.
  • EyePoint Pharmaceuticals, Inc. Operating Lease, Right-of-Use Asset for the quarter ending June 30, 2024 was $22.3M, a 304% increase year-over-year.
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 $22.3M +$16.8M +304% Jun 30, 2024 10-Q 2024-08-08
Q1 2024 $4.71M -$1.07M -18.5% Mar 31, 2024 10-Q 2024-05-09
Q4 2023 $4.98M -$1.06M -17.5% Dec 31, 2023 10-Q 2024-08-08
Q3 2023 $5.25M -$1.07M -16.9% Sep 30, 2023 10-Q 2023-11-03
Q2 2023 $5.51M +$2.61M +90.1% Jun 30, 2023 10-Q 2023-08-04
Q1 2023 $5.78M +$3.68M +175% Mar 31, 2023 10-Q 2023-05-04
Q4 2022 $6.04M +$3.79M +168% Dec 31, 2022 10-K 2024-03-08
Q3 2022 $6.32M +$3.92M +163% Sep 30, 2022 10-Q 2022-11-04
Q2 2022 $2.9M +$547K +23.2% Jun 30, 2022 10-Q 2023-11-03
Q1 2022 $2.1M -$387K -15.6% Mar 31, 2022 10-Q 2022-05-06
Q4 2021 $2.25M -$358K -13.7% Dec 31, 2021 10-K 2023-03-10
Q3 2021 $2.4M -$331K -12.1% Sep 30, 2021 10-Q 2021-11-05
Q2 2021 $2.35M -$499K -17.5% Jun 30, 2021 10-Q 2021-08-06
Q1 2021 $2.48M -$483K -16.3% Mar 31, 2021 10-Q 2021-05-05
Q4 2020 $2.61M -$468K -15.2% Dec 31, 2020 10-K 2022-03-14
Q3 2020 $2.73M -$453K -14.2% Sep 30, 2020 10-Q 2020-11-06
Q2 2020 $2.85M -$439K -13.3% Jun 30, 2020 10-Q 2020-08-05
Q1 2020 $2.97M -$426K -12.6% Mar 31, 2020 10-Q 2020-05-08
Q4 2019 $3.08M +$3.08M Dec 31, 2019 10-K 2021-03-12
Q3 2019 $3.19M Sep 30, 2019 10-Q 2019-11-07
Q2 2019 $3.29M Jun 30, 2019 10-Q 2019-08-07
Q1 2019 $3.39M Mar 31, 2019 10-Q 2019-05-10
Q4 2018 $0 Dec 31, 2018 10-K 2020-03-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.